VYLDA 50MG TABLET 15'S
By EMCURE PHARMACEUTICALS LIMITED
Contains: VILDAGLIPTIN 50 MG
About VYLDA 50MG TABLET 15'S
- VYLDA 50MG TABLET 15'S is a medication that is used to treat type 2 diabetes. It is an oral medication that belongs to a class of drugs called dipeptidyl peptidase-4 (DPP-4) inhibitors. VYLDA 50MG TABLET 15'S works by increasing the levels of incretin hormones, which help to regulate blood sugar levels.
- VYLDA 50MG TABLET 15'S is typically prescribed in combination with other medications to help control blood sugar levels in patients with type 2 diabetes. It is often used in combination with METFORMIN, which is another medication that helps to lower blood sugar levels.
- The medication is typically taken orally, either once or twice daily, depending on the dosage prescribed by a healthcare provider. The dosage of VYLDA 50MG TABLET 15'S will depend on several factors, including a patient's age, weight, overall health, and other medical conditions they may have.
- Like all medications, VYLDA 50MG TABLET 15'S may cause side effects. The most common side effects of VYLDA 50MG TABLET 15'S include headache, dizziness, nausea, vomiting, diarrhea, and upper respiratory tract infections. In rare cases, VYLDA 50MG TABLET 15'S can cause more serious side effects, such as pancreatitis, allergic reactions, or liver problems.
- If you are taking VYLDA 50MG TABLET 15'S or any other medication to manage your diabetes, it is important to follow your healthcare provider's instructions carefully. You should also monitor your blood sugar levels regularly and report any changes or symptoms to your healthcare provider.
- In summary, VYLDA 50MG TABLET 15'S is a medication that can be helpful in managing type 2 diabetes, but it should be used as part of a comprehensive treatment plan that includes regular monitoring, lifestyle changes, and other medications as needed.
Uses of VYLDA 50MG TABLET 15'S
- Is used in lowering Blood sugar levels
- Is used to treat Combination therapy
- Is used to treat Cardiovascular risk reduction
- Is used to treat Beta-cell function
- Helps to improve Glycemic control
How VYLDA 50MG TABLET 15'S Works
- VYLDA 50MG TABLET 15'S works by inhibiting the enzyme dipeptidyl peptidase-4 (DPP-4), which is responsible for breaking down incretin hormones in the body
- Incretin hormones are released by the intestines after a meal and help to stimulate insulin secretion from the pancreas, which in turn helps to regulate blood sugar levels.
- By inhibiting DPP-4, VYLDA 50MG TABLET 15'S increases the levels of incretin hormones in the body, which helps to stimulate insulin secretion and reduce blood sugar levels. This makes VYLDA 50MG TABLET 15'S an effective medication for managing high blood sugar levels in patients with type 2 diabetes.
- VYLDA 50MG TABLET 15'S has also been shown to have other effects on the body, including improving beta-cell function, reducing the production of glucose by the liver, and increasing the sensitivity of tissues to insulin. These effects can help to improve glycemic control and reduce the risk of diabetes-related complications.
Dosage of VYLDA 50MG TABLET 15'S Works
- For Children: The use of VYLDA 50MG TABLET 15'S in children has not been established, and the medication is not approved for use in children under the age of 18. Therefore, the dosage for children cannot be provided.
- For Adults: The dosage of VYLDA 50MG TABLET 15'S for adults may vary depending on various factors such as age, weight, medical condition, and other medications being taken. The recommended dose of VYLDA 50MG TABLET 15'S for most adult patients with type 2 diabetes is typically 50mg twice daily, taken with meals.
Side Effects Of VYLDA 50MG TABLET 15'S
- Headache
- Dizziness
- Nausea
- Vomiting
- Diarrhea
- Upper respiratory tract infections
How to Store VYLDA 50MG TABLET 15'S
- Store VYLDA 50MG TABLET 15'S tablets at room temperature, between 15°C and 30°C (59°F and 86°F).
- Protect VYLDA 50MG TABLET 15'S tablets from moisture and light by keeping them in their original packaging until ready to use.
- Do not store VYLDA 50MG TABLET 15'S in the bathroom or other humid areas.
- Keep VYLDA 50MG TABLET 15'S out of the reach of children and pets.
Frequently asked questions about VYLDA 50MG TABLET 15'S
VYLDA 50MG TABLET 15'S is used to treat type 2 diabetes by helping to regulate blood sugar levels. It is typically used in combination with diet and exercise, as well as other medications as needed.
The most common side effects of VYLDA 50MG TABLET 15'S include headache, dizziness, nausea, vomiting, diarrhea, and upper respiratory tract infections. In rare cases, it may cause more serious side effects such as pancreatitis, hypoglycemia, allergic reactions, or liver problems.
VYLDA 50MG TABLET 15'S is not approved for use in children under the age of 18, and its safety and efficacy in this population have not been established.
VYLDA 50MG TABLET 15'S is usually taken orally, with meals. The recommended dosage may vary depending on the individual needs and response of the patient, and it should be determined by a healthcare provider.
The use of VYLDA 50MG TABLET 15'S during pregnancy or breastfeeding is not recommended, as its safety in these situations has not been established. Women who are pregnant or breastfeeding should consult with their healthcare provider before taking VYLDA 50MG TABLET 15'S or any other medication.
Patients with moderate to severe kidney or liver problems should use VYLDA 50MG TABLET 15'S with caution and at a reduced dose. A healthcare provider should be consulted before taking VYLDA 50MG TABLET 15'S in these situations.
If a dose of VYLDA 50MG TABLET 15'S is missed, it should be taken as soon as possible unless it is close to the time of the next scheduled dose. In that case, the missed dose should be skipped, and the regular dosing schedule should be resumed.
VYLDA 50MG TABLET 15'S should be stored at room temperature, between 20°C to 25°C (68°F to 77°F), in a dry place away from direct sunlight and heat. It should be kept in its original packaging until it is ready to be used. Unused or expired medication should be disposed of properly according to local regulations.
References related to VYLDA 50MG TABLET 15'S
- ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS. (n.d.). Retrieved from https://www.ema.europa.eu/en/documents/product-information/galvus-epar-product-information_en.pdf
- VYSOV Tablets. (2018). Retrieved May 4, 2023, from CiplaMed website: https://ciplamed-library.com/content/vysov-tablets
- Bosi, E., Camisasca, R. P., Collober, C., Rochotte, E., & Garber, A. J. (2007). Effects of Vildagliptin on Glucose Control Over 24 Weeks in Patients With Type 2 Diabetes Inadequately Controlled With Metformin. Diabetes Care, 30(4), 890–895. https://doi.org/10.2337/dc06-1732
Ashish Makwana
Reviewed on 12 Jan 2024
Ashish Makwana
Reviewed on 12 Jan 2024
Excellent Customer service
Mohit Tanna
Reviewed on 30 Jan 2024
Mohit Tanna
Reviewed on 30 Jan 2024
Best medicine 💊
ujjawal bhatt
Reviewed on 08 Jan 2024
ujjawal bhatt
Reviewed on 08 Jan 2024
Good discount available on Generic medicines and supportive staff. Thank you.
Prince Sharma
Reviewed on 18 Apr 2023
Prince Sharma
Reviewed on 18 Apr 2023
Happy
Shubham Jain
Reviewed on 23 Nov 2022
Shubham Jain
Reviewed on 23 Nov 2022
Best and cheapest medicine.